GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Siegfried Holding AG (XSWX:SFZN) » Definitions » EBIT

Siegfried Holding AG (XSWX:SFZN) EBIT : CHF160 Mil (TTM As of Dec. 2023)


View and export this data going back to 1973. Start your Free Trial

What is Siegfried Holding AG EBIT?

Siegfried Holding AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was CHF81 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF160 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Siegfried Holding AG's annualized ROC % for the quarter that ended in Dec. 2023 was 8.27%. Siegfried Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 12.57%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Siegfried Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.29%.


Siegfried Holding AG EBIT Historical Data

The historical data trend for Siegfried Holding AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siegfried Holding AG EBIT Chart

Siegfried Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.59 76.93 130.43 226.37 159.68

Siegfried Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.45 86.53 139.85 79.15 80.52

Competitive Comparison of Siegfried Holding AG's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siegfried Holding AG's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Siegfried Holding AG's EV-to-EBIT falls into.



Siegfried Holding AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF160 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Siegfried Holding AG  (XSWX:SFZN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Siegfried Holding AG's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=173.35 * ( 1 - 23.88% )/( (1588.285 + 1602.987)/ 2 )
=131.95402/1595.636
=8.27 %

where

Invested Capital(Q: Jun. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1767.998 - 149.054 - ( 30.659 - max(0, 306.856 - 904.564+30.659))
=1588.285

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1861.505 - 201.892 - ( 56.626 - max(0, 397.8 - 983.164+56.626))
=1602.987

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Siegfried Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=161.048/( ( (789.34 + max(527.589, 0)) + (801.072 + max(444.799, 0)) )/ 2 )
=161.048/( ( 1316.929 + 1245.871 )/ 2 )
=161.048/1281.4
=12.57 %

where Working Capital is:

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(281.238 + 486.501 + 66.706) - (149.054 + 0 + 157.802)
=527.589

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(347.357 + 431.938 + 63.304) - (201.892 + 0 + 195.908)
=444.799

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Siegfried Holding AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=159.676/3722.289
=4.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Siegfried Holding AG EBIT Related Terms

Thank you for viewing the detailed overview of Siegfried Holding AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Siegfried Holding AG (XSWX:SFZN) Business Description

Traded in Other Exchanges
Address
Untere Bruehlstrasse 4, Zofingen, CHE, CH-4800
Siegfried Holding AG is a biotechnology company that focuses on primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile fillings. The company broadly offers complex oral and sterile formulations of drug products available for custom development and manufacturing, as well as licensing.

Siegfried Holding AG (XSWX:SFZN) Headlines

No Headlines